Crossmark

Prognostic value of the aggregate index of systemic inflammation in predicting in-hospital adverse outcomes among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention

Crossref DOI link: https://doi.org/10.1186/s12872-026-06157-1

Published Online: 2026-06-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kahraman, Erkan

Parsova, Kemal Emrecan

Durak, Furkan

Gumusdag, Ayca

Iskender, Hakan

Cakir, Bilal

Velibey, Yalcin
License Information

Text and Data Mining valid from 2026-06-22

Version of Record valid from 2026-09-07
More Information

Article History

Received: 26 December 2025

Accepted: 17 June 2026

First Online: 22 June 2026

Declarations

Ethics approval and consent to participate: Ethical approval for this study was obtained from the Ethics Committee of Istanbul Medipol University (registration code E-10840098-202.3.02-5847, Date: 28.08.2025). All human studies were conducted according to the principles outlined in the 1964 Declaration of Helsinki.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below